Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA Budget Issues Creep Into Strategic Priorities

This article was originally published in The Pink Sheet Daily

Executive Summary

“Given the limited availability of investment capital for medical product development, early clarification of regulatory requirements is critical,” FDA says.

You may also be interested in...



FDA Gives Innovation, Harmonization Added Attention In Final Priorities Report

The agency made subtle but potentially notable changes from a draft in its final five-year strategic priorities document, released Sept. 30.

FDA Gives Innovation, Harmonization Added Attention In Final Priorities Report

Industry comments lead to subtle but notable changes; agency also makes a few deletions, additions of its own including deemphasizing cost-control projects, highlighting antibiotic development and changing the status of its facility improvements.

FDA Gives Innovation, Harmonization Added Attention In Final Priorities Report

Industry comments lead to subtle but notable changes; agency also makes a few deletions, additions of its own including deemphasizing cost-control projects, highlighting antibiotic development and changing the status of its facility improvements.

Related Content

Topics

UsernamePublicRestriction

Register

PS077458

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel